Dr. Ta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2452 Watson Ct
Palo Alto, CA 94303Phone+1 650-723-6995Fax+1 650-725-6619- Is this information wrong?
Summary
- Christopher N. Ta, MD specializes in the diagnosis and treatment of cornea diseases including medical and surgical management. His areas of expertise are in the treatment of ocular infections, inflammation, dry eyes and ocular surface diseases. He has conducted numerous clinical trials toward the prevention and treatment of ocular infections. Dr. Ta’s interests include diagnostic testing and evaluation of novel drugs and devices in the treatment of ocular surface diseases. Dr. Ta has extensive clinical experience in the treatment of ocular graft-versus host disease following hematopoietic stem cell transplantation.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Cornea, External Diseases, and Refractive Surgery, 1998 - 1999
- Stanford Health Care-Sponsored Stanford UniversityResidency, Ophthalmology, 1995 - 1998
- Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 1994 - 1995
- University of Minnesota Medical SchoolClass of 1994
- University of MinnesotaBA, Human Physiology, 1987 - 1990
Certifications & Licensure
- CA State Medical License 1995 - 2025
- TX State Medical License 1998 - 1999
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- One Hour Preoperative Gatifloxacin Start of enrollment: 2007 Jan 01
- Topical Antibiotics and Intravitreous Injections Start of enrollment: 2008 Jul 01
- Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour Application Start of enrollment: 2007 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsTherapeutic contact lenses for the treatment of corneal and ocular surface diseases: Advances in extended and targeted drug delivery.Behnam Abdi, Mohammad Mofidfar, Fatemeh Hassanpour, Emel Kirbas Cilingir, Sepideh K Kalajahi, Paria H Milani, Mahsa Ghanbarzadeh, Daddi Fadel, Melissa Barnett, Christo...> ;International Journal of Pharmaceutics. 2023 May 10
- 2 citationsObservational study of cenegermin for the treatment of limbal stem cell deficiency associated with neurotrophic keratopathy.Alejandro Arboleda, Christopher N Ta> ;Therapeutic Advances in Ophthalmology. 2022 Nov 4
- 4 citationsA Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease.Alan Sugar, Munira Hussain, Winston Chamberlain, Reza Dana, David Patrick Kelly, Christopher Ta, John Irvine, Melissa Daluvoy, Victor Perez, Joshua Olson, Vishal Jhanj...> ;Ophthalmology Science. 2022 Sep 1
- Join now to see all
Grant Support
- Artificial Cornea Based On Photolithographically Patterned, Biomimetic HydrogelsNational Eye Institute2007–2010
Professional Memberships
- Fellow
Hospital Affiliations
- Stanford Health CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: